/ /

Cataract & Refractive
Steroid and NSAID combination ...

A combination of a topical corticosteroid and a nonsteroidal anti-inflammatory drug (NSAID) is more effective than either ...

Testing at point of care for ...
Adopting a multidiagnostic method ...
Long-term observation of SMILE gives ...
Retina
Diagnosing and treating MacTel ...

Idiopathic macular telangiectasia (MacTel) is bilateral condition characterised by ectatic capillaries of the macula and ...

Confocal scanner gives ...
Gene therapy trial launched for ...
Patients’ health jeopardized by ...
Glaucoma
Applying micropulse transscleral ...

Micropulse transscleral cyclophotocoagulation utilises a different delivery modality than its predecessor, ...

Exploring safety, efficacy of ...
Studying aqueous humour outflow with ...
Glaucoma monitoring implant receives ...

Latest Issue

::after
::after

OTE Articles

Steroid and NSAID combination prevents macular oedema after cataractsA combination of a topical corticosteroid and a nonsteroidal anti-inflammatory drug (NSAID) is more effective than either one alone in reducing the risk of cystoid macular oedema (CME) after cataract surgery in nondiabetic patients, researchers say.
Testing at point of care for improved patient satisfaction, re-treatment ratesAfter spending a few months testing for dry eye and treating the tear film before doing preoperative measurements, the re-treatment rate dropped from 11% to 3%.
Adopting a multidiagnostic method for characterising the anterior segmentA multidiagnostic device is able to provide consistent measurements of refraction and ocular aberrations in healthy eyes. The consistency of refractive measurements is not dependent on the magnitude of the refractive error, with the same precision ability for moderate to high myopia and for hyperopia.
Long-term observation of SMILE gives better myopia prognosisLong-term observation of SMILE reveals high stability at various degrees of correction of myopia. This allows surgeons who apply this method of treatment to give patients a long-term prognosis.
Low-dose atropine for myopia in children: two years of experienceChildren in Tel Aviv have been treated with nightly atropine drops, significantly slowing the progression of myopia.
Applying micropulse transscleral cyclophotocoagulation for early-stage glaucoma Micropulse transscleral cyclophotocoagulation utilises a different delivery modality than its predecessor, continuous-wave laser cycloablation, to produce a biological reaction without the lethal effects caused by thermal buildup.
Yet another new revolution in ocular surface imagingDuring the past two decades, an incredible number of imaging technologies have been developed for eye diseases, both for diagnosis and follow-up.
Helping the underprivileged to seeRoughly 300 million people are visually impaired—38 million of whom are blind and most of whom live in so-called developing countries. However, there are many institutions with specific campaigns aimed at eliminating preventable blindness.
How to improve IOL power calculations in keratoconusOne source of error in IOL power calculation is the use of the classical keratometric approach for the characterisation of the corneal optics. This approach is based on the assumption of only one corneal surface and a fictitious index of refraction (keratometric index, nk) for obtaining an estimation of the corneal power (Pk).
European Commission approves adalimumab for paediatric uveitisThe European Commission has approved adalimumab (Humira, AbbVie) as the first biologic treatment for chronic non-infectious anterior uveitis in paediatric patients from 2 years of age who have had an inadequate response to conventional therapy.